Abstract
Extracellular ATP and nicotinamide adenine dinucleotide (β-NAD) demonstrate properties of neurotransmitters and neuromodulators in peripheral and central nervous system. It has been shown previously that ATP and β-NAD affect cardiac functioning in adult mammals. Nevertheless, the modulation of cardiac activity by purine compounds in the early postnatal development is still not elucidated. Also, the potential influence of ATP and β-NAD on cholinergic neurotransmission in the heart has not been investigated previously. Age-dependence of electrophysiological effects produced by extracellular ATP and β-NAD was studied in the rat myocardium using sharp microelectrode technique. ATP and β-NAD could affect ventricular and supraventricular myocardium independent from autonomic influences. Both purines induced reduction of action potentials (APs) duration in tissue preparations of atrial, ventricular myocardium, and myocardial sleeves of pulmonary veins from early postnatal rats similarly to myocardium of adult animals. Both purine compounds demonstrated weak age-dependence of the effect. We have estimated the ability of ATP and β-NAD to alter cholinergic effects in the heart. Both purines suppressed inhibitory effects produced by stimulation of intracardiac parasympathetic nerve in right atria from adult animals, but not in preparations from neonates. Also, ATP and β-NAD suppressed rest and evoked release of acetylcholine (ACh) in adult animals. β-NAD suppressed effects of parasympathetic stimulation and ACh release stronger than ATP. In conclusion, ATP and β-NAD control the heart at the postsynaptic and presynaptic levels via affecting the cardiac myocytes APs and ACh release. Postsynaptic and presynaptic effects of purines may be antagonistic and the latter demonstrates age-dependence.
Similar content being viewed by others
Abbreviations
- ACh:
-
Acetylcholine
- AF:
-
Atrial fibrillation
- AP:
-
Action potential
- APD:
-
Action potential duration
- APD90:
-
Action potential duration at 90% of repolarization
- LA:
-
Left atrium
- NST:
-
Neostigmine
- P1:
-
1st day of postnatal development
- P14:
-
14st day of postnatal development
- P21:
-
21st day of postnatal development
- PV:
-
Pulmonary vein
- RA:
-
Right atrium
- RV:
-
Right ventricular wall
- SAP:
-
Spontaneous action potential
- β-NAD:
-
β-nicotinamide adenine dinucleotide
References
Hoyle CH, Burnstock G (1986) Evidence that ATP is a neurotransmitter in the frog heart. Eur J Pharmacol 124:285–289
Burnstock G (2009) Purinergic cotransmission. F1000 Biol Rep 1:46. https://doi.org/10.3410/B1-46
Burnstock G (2013) Cotransmission in the autonomic nervous system. Handb Clin Neurol 117:23–35. https://doi.org/10.1016/B978-0-444-53491-0.00003-1
Kennedy C (2015) ATP as a cotransmitter in the autonomic nervous system. Auton Neurosci 191:2–15. https://doi.org/10.1016/j.autneu.2015.04.004
Alefishat E, Alexander SPH, Ralevic V (2015) Effects of NAD at purine receptors in isolated blood vessels. Purinergic Signal 11:47–57. https://doi.org/10.1007/s11302-014-9428-1
Mutafova-Yambolieva VN, Hwang SJ, Hao X, Chen H, Zhu MX, Wood JD, Ward SM, Sanders KM (2007) Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle. Proc Natl Acad Sci U S A 104:16359–16364. https://doi.org/10.1073/pnas.0705510104
Hwang SJ, Blair PJ, Durnin L, Mutafova-Yambolieva V, Sanders KM, Ward SM (2012) P2Y1 purinoreceptors are fundamental to inhibitory motor control of murine colonic excitability and transit. J Physiol 590:1957–1972. https://doi.org/10.1113/jphysiol.2011.224634
Mutafova-Yambolieva VN, Durnin L (2014) The purinergic neurotransmitter revisited: a single substance or multiple players. Pharmacol Ther 144:162–191. https://doi.org/10.1016/j.pharmthera.2014.05.012
Burnstock G, Hoyle CH (1985) Actions of adenine dinucleotides in the Guinea-pig taenia coli: NAD acts indirectly on P1-purinoceptors; NADP acts like a P2-purinoceptor agonist. Br J Pharmacol 84:825–831
Pustovit KB, Kuzmin VS, Sukhova GS (2015) Effect of exogenous extracellular nicotinamide adenine dinucleotide (nad+) on bioelectric activity of the pacemaker and conduction system of the heart. Bull Exp Biol Med 159(2):188–191. https://doi.org/10.1007/s10517-015-2919-4
Smyth LM, Bobalova J, Mendoza MG, Lew C, Mutafova-Yambolieva VN (2004) Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. J Biol Chem 279:48893–48903. https://doi.org/10.1074/jbc.M407266200
Ribeiro JA, Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54:213–218
Ribeiro JA, Cunha RA, Correia-de-Sa P, Sebastiao AM (1996) Purinergic regulation of acetylcholine release. Prog Brain Res 109:231–241
Burnstock G, Cocks T, Crowe R, Kasakov L (1978) Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol 63:125–138
Breen LT, Smyth LM, Yamboliev IA, Mutafova-Yambolieva VN (2006) Beta-NAD is a novel nucleotide released on stimulation of nerve terminals in human urinary bladder detrusor muscle. Am J Physiol Renal Physiol 290:F486–F495. https://doi.org/10.1152/ajprenal.00314.2005
Cheung K, Ryten M, Burnstock G (2003) Abundant and dynamic expression of G protein-coupled P2Y receptors in mammalian development. Dev Dyn 228(2):254–266. https://doi.org/10.1002/dvdy.10378
Bogdanov Y, Rubino A, Burnstock G (1998) Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart. Life Sci 62(8):697–703
Webb TE, Boluyt MO, Barnard EA (1996) Molecular biology of P2Y purinoceptors: expression in rat heart. J Auton Pharmacol 16:303–307
Tsai KJ, Tsai YC, Shen CK (2007) G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med 204(6):1273–1280
Petrov AM, Naumenko NV, Uzinskaya KV, Giniatullin AR, Urazaev AK, Zefirov AL (2011) Increased non-quantal release of acetylcholine after inhibition of endocytosis by methyl-β-cyclodextrin: the role of vesicular acetylcholine transporter. Neuroscience 186:1–12. https://doi.org/10.1016/j.neuroscience.2011.04.051
Odnoshivkina UG, Sytchev VI, Nurullin LF, Giniatullin AR, Zefirov AL, Petrov AM (2015) β2-adrenoceptor agonist-evoked reactive oxygen species generation in mouse atria: implication in delayed inotropic effect. Eur J Pharmacol 765:140–153. https://doi.org/10.1016/j.ejphar.2015.08.020
Abramochkin DV, Nurullin LF, Borodinova AA, Tarasova NV, Sukhova GS, Nikolsky EE, Rosenshtraukh LV (2010) Non-quantal release of acetylcholine from parasympathetic nerve terminals in the right atrium of rats. 95(2):265–273. https://doi.org/10.1113/expphysiol.2009.050302
Anikina TA, Bilalova GA, Zverev AA, Sitdikov FG (2007) Effect of ATP and its analogs on contractility of rat myocardium during ontogeny. Bull Exp Biol Med 144:4–7. https://doi.org/10.1007/s10517-007-0239-z
Vassort G (2001) Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81:767–806
Kuzmin VS, Pustovit KB, Abramochkin DV (2016) Effects of exogenous nicotinamide adenine dinucleotide (NAD+) in the rat heart are mediated by P2 purine receptors. J Biomed Sci 23(50):50. https://doi.org/10.1186/s12929-016-0267-y
Doisne N, Maupoil V, Cosnay P, Findlay I (2009) Catecholaminergic automatic activity in the rat pulmonary vein: electrophysiological differences between cardiac muscle in the left atrium and pulmonary vein. Am J Physiol Heart Circ Physiol 297(1):H102–H108. https://doi.org/10.1152/ajpheart.00256.2009
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339(10):659–666
Schotten U, Verheule S, Kirchhof P, Goette A (2011) Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 91(1):265–325
Sharma AD, Klein GJ (1988) Comparative quantitative electrophysiologic effects of adenosine triphosphate on the sinus node and atrioventricular node. Am J Cardiol 61:330–335
Pelleg A, Belhassen B (2010) The mechanism of the negative chronotropic and dromotropic actions of adenosine 5′-triphosphate in the heart: an update. J Cardiovasc Pharmacol 56:106–109. https://doi.org/10.1097/FJC.0b013e3181e0f8b2
Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8:661. https://doi.org/10.3389/fphar.2017.00661
Pelleg A (2017) Electrophysiologic effects of adenosine versus ATP. J Cardiovasc Electrophysiol 28:E5. https://doi.org/10.1111/jce.13243
Billington RA, Bruzzone S, De Flora A, Genazzani AA, Koch-Nolte F, Ziegler M, Zocchi E (2006) Emerging functions of extracellular pyridine nucleotides. Mol Med 12:324–327. https://doi.org/10.2119/2006-00075
Schwarz N, Fliegert R, Adriouch S, Seman M, Guse AH, Haag F, Koch-Nolte F (2009) Activation of the P2X7 ion channel by soluble and covalently bound ligands. Purinergic Signal 5:139–149. https://doi.org/10.1007/s11302-009-9135-5
Erlinge D, Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4(1):1–20. https://doi.org/10.1007/s11302-007-9078-7
Hwang S, Blair P, Durnin L, Mutafova-Yambolieva V, Sanders K, Ward S (2012) P2Y1 purinoreceptors are fundamental to inhibitory motor control of murine colonic excitability and transit. J Physiol 590(8):1957–1972. https://doi.org/10.1113/jphysiol.2011.224634
Moreschi I, Bruzzone S, Nicholas RA, Fruscione F, Sturla L, Benvenuto F, Usai C, Meis S, Kassack MU, Zocchi E, De Flora A (2006) Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J Biol Chem 281:31419–31429. https://doi.org/10.1074/jbc.M606625200
Dreisig K, Kornum BR (2016) A critical look at the function of the P2Y11 receptor. Purinergic Signal 12(3):427–437. https://doi.org/10.1007/s11302-016-9514-7
Kennedy C (2017) P2Y(11) receptors: properties, distribution and functions. Adv Exp Med Biol 1051:107–122. https://doi.org/10.1007/5584
Nishimura A, Sunggip C, Oda S, Numaga-Tomita T, Tsuda M, Nishida M (2017) Purinergic P2Y receptors: molecular diversity and implications for treatment of cardiovascular diseases. Pharmacol Ther 180:113–128. https://doi.org/10.1016/j.pharmthera.2017.06.010
Abramochkin DV, Tapilina SV, Sukhova GS, Nikolsky EE, Nurullin LF (2012) Functional M3 cholinoreceptors are present in pacemaker and working myocardium of murine heart. Pflugers Arch 463(4):523–529. https://doi.org/10.1007/s00424-012-1075-1
Wang H, Lu Y, Wang Z (2007) Function of cardiac M3 receptors. Auton Autocoid Pharmacol 27:1–11. https://doi.org/10.1111/j.1474-8673.2006.00381.x
Tapilina SV, Abramochkin DV (2016) Decrease in the sensitivity of myocardium to M3 muscarinic receptor stimulation during postnatal ontogenisis. Acta Nat 8(2):127–131
Wootten D, Christopoulos A, Marti-Solano M, Babu MM, Sexton PM (2018) Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat Rev Mol Cell Biol 19:638–653. https://doi.org/10.1038/s41580-018-0049-3
Glitsch HG, Pott L (1978) Effects of acetylcholine and parasympathetic nerve stimulation on membrane potential in quiescent guinea-pig atria. J Physiol 279:655–668
Takei M, Furukawa Y, Narita M, Ren LM, Karasawa Y, Murakami M, Chiba S (1991) Synergistic nonuniform shortening of atrial refractory period induced by autonomic stimulation. Am J Phys 261:H1988–H1993
Chiba S (1978) Selective stimulation of intracardiac pre-ganglionic vagal fibres of the dog atrium. Clin Exp Pharmacol Physiol 5:465–469
Ribeiro JA, Walker J (1973) Action of adenosine triphosphate on endplate potentials recorded from muscle fibres of the rat-diaphragm and frog sartorius. Br J Pharmacol 49:724–725
Ribeiro J, Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54(2):213–218
Guarracino JF, Cinalli AR, Fernandez V, Roquel LI, Losavio AS (2016) P2Y13 receptors mediate presynaptic inhibition of acetylcholine release induced by adenine nucleotides at the mouse neuromuscular junction. Neuroscience 326:31–44. https://doi.org/10.1016/j.neuroscience.2016.03.066
Ribeiro JA, Dominguez ML (1978) Mechanisms of depression of neuromuscular transmission by ATP and adenosine. J Physiol 74:491–496
Pelleg A, Hurt CM, Hewlett EL (1996) ATP shortens atrial action potential duration in the dog: role of adenosine, the vagus nerve, and G protein. Can J Physiol Pharmacol 74:15–22
Marvin WJ Jr, Hermsmeyer K, McDonald RI, Roskoski LM, Roskoski R Jr (1980) Ontogenesis of cholingergic innervation in the rat heart. Circ Res 46(5):690–695
Vyskocil F, Malomouzh AI, Nikolsky EE (2009) Non-quantal acetylcholine release at the neuromuscular junction. Physiol Res 58(6):763–784
Nassenstein C, Wiegand S, Lips KS, G4 L, Klein J, Kummer W (2015) Cholinergic activation of the murine trachealis muscle via non-vesicular acetylcholine release involving low-affinity choline transporters. 29(1):173–180. https://doi.org/10.1016/j.intimp.2015.08.007
Malomouzh AI, Nikolsky EE, Vyskocil F (2011) Purine P2Y receptors in ATP-mediated regulation of non-quantal acetylcholine release from motor nerve endings of rat diaphragm. Neurosci Res 71:219–225. https://doi.org/10.1016/j.neures.2011.07.1829
Galkin AV, Giniatullin RA, Mukhtarov MR, Svandova I, Grishin SN, Vyskocil F (2001) ATP but not adenosine inhibits nonquantal acetylcholine release at the mouse neuromuscular junction. Eur J Neurosci 13:2047–2053
Funding
This study was supported by Russian Science Foundation grant 14-15-00268.
Author information
Authors and Affiliations
Contributions
Participated in the study planning: Kuzmin VS.
Performed experiments and data analysis: Pustovit KB, Potekhina VM, Ivanova AD.
Contributed to the discussion and reviewed/edited the manuscript: Petrov AM.
Wrote the manuscript: Abramochkin DV, Kuzmin VS.
Corresponding author
Ethics declarations
Conflicts of interest
Pustovit KB declares that she has no conflict of interest.
Potekhina VM declares that she has no conflict of interest.
Ivanova AD declares that she has no conflict of interest.
Petrov AM declares that he has no conflict of interest.
Abramochkin DV declares that he has no conflict of interest.
Kuzmin VS declares that he has no conflict of interest.
Ethical approval
This study was approved by Bioethics Committee of Moscow State University.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pustovit, K.B., Potekhina, V.M., Ivanova, A.D. et al. Extracellular ATP and β-NAD alter electrical properties and cholinergic effects in the rat heart in age-specific manner. Purinergic Signalling 15, 107–117 (2019). https://doi.org/10.1007/s11302-019-09645-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-019-09645-6